Publications by authors named "Konstantin Doberer"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

3,834

Total Likes

367

Extended Reach

3,457,519

Social Features

139
A
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Katharina A Mayer, Eva Schrezenmeier, Matthias Diebold, Philip F Halloran, Martina Schatzl, Sabine Schranz, Susanne Haindl, Silke Kasbohm, Alexander Kainz, Farsad Eskandary

N Engl J Med· July 2024

Videos about Article: user user

2 1 10 136 3 2 14

View All Article and Social Media Activity
I
Immune Monitoring Goes Viral - Torque Teno Virus for Immunologic Risk Stratification After Kidney Transplantation.
Konstantin Doberer, Sebastian Kapps, Frederik Haupenthal, Gregor Bond

Transpl Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients.
Frederik Haupenthal, Konstantin Doberer, Sebastian Kapps, Johannes Kläger, Florian Bauernfeind

Nephrol Dial Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical analysis plan for TTVguideIT-a multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and Torque Teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation.
Felix Herkner, Frederik Haupenthal, Sebastian Kapps, Konstantin Doberer, Harald Herkner

Trials· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated infection with Candida dubliniensis after ravulizumab and treatment with rezafungin - a case report.
Felix Lötsch, Michael Eder, Haris Omic, Konstantin Doberer, Martina Scharitzer

J Mycol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study.
Matthias Diebold, Hannes Vietzen, Martina Schatzl, Katharina A Mayer, Susanne Haindl, Konstantin Doberer

Transplantation· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX).
Roman Reindl-Schwaighofer, Andreas Heinzel, Lukas Raab, Robert Strassl, Carsten T Herz, Konstantin Doberer

EBioMedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyomavirus Nephropathy in ABO Blood Group-Incompatible Kidney Transplantation: Torque Teno Virus and Immunosuppressive Burden as an Approximation to the Problem.
Michael Eder, Tarek A Schrag, Ella F Havel, Alexander Kainz, Haris Omic, Konstantin Doberer

Kidney Int Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.
Matthias Diebold, Hannes Vietzen, Andreas Heinzel, Susanne Haindl, Carsten T Herz, Konstantin Doberer

Am J Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients.
Florina Regele, Frederik Haupenthal, Konstantin Doberer, Irene Görzer, Sebastian Kapps

J Med Virol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial.
Anna Redl, Konstantin Doberer, Luisa Unterluggauer, Lisa Kleissl, Christoph Krall

Lancet Rheumatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional Decline.
Carsten T Herz, Matthias Diebold, Alexander Kainz, Katharina A Mayer, Konstantin Doberer

Transpl Int· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
Frederik Haupenthal, Jette Rahn, Fabrizio Maggi, Fanny Gelas, Philippe Bourgeois, Konstantin Doberer

Trials· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena.
Anita Borski, Farsad Eskandary, Susanne Haindl, Konstantin Doberer, Jakob Mühlbacher

Transplantation· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation.
Thomas Krausgruber, Anna Redl, Daniele Barreca, Konstantin Doberer, Daria Romanovskaia

Immunity· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10.
Katharina A Mayer, Konstantin Doberer, Philip F Halloran, Klemens Budde, Susanne Haindl

Transplant Direct· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.
Katharina A Mayer, Haris Omic, Lukas Weseslindtner, Konstantin Doberer, Roman Reindl-Schwaighofer

Clin Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinuria in Deceased Kidney Transplant Donors for Prediction of Chronic Lesions in Pretransplant Biopsies: A Prospective Observational Study.
Frederik Haupenthal, Johannes Kläger, Florian Bauernfeind, Andreas Heinzel, Konstantin Doberer

Transplantation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials.
Katharina A Mayer, Klemens Budde, Bernd Jilma, Konstantin Doberer, Georg A Böhmig

Expert Opin Emerg Drugs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial.
Katharina A Mayer, Klemens Budde, Philip F Halloran, Konstantin Doberer, Lionel Rostaing

Trials· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection.
Anita Borski, Alexander Kainz, Nicolas Kozakowski, Heinz Regele, Johannes Kläger, Konstantin Doberer

Front Med (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Roman Reindl-Schwaighofer, Andreas Heinzel, Manuel Mayrdorfer, Rhea Jabbour, Thomas M Hofbauer, Konstantin Doberer

JAMA Intern Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial.
Konstantin Doberer, Frederik Haupenthal, Maja Nackenhorst, Florian Bauernfeind, Florentina Dermuth

Transplantation· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
Katharina A Mayer, Konstantin Doberer, Amanda Tillgren, Thierry Viard, Susanne Haindl

Transpl Int· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
Jakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer, Michael Dürr, Klemens Budde

Transpl Int· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis